Enviroclenz

Berberis Vulgaris, Carduus Marianus, Chelidonium Majus, Glycyrrhiza Glabra, Lappa Major, Rhamnus Frangula, Stillingia Sylvatica, Taraxacum Officinale, Trifolium Pratense, Phytolacca Decandra, Germanium Sesquioxide, Benzinum, Chlorinum, Acetone, Ammonium Muriaticum, Propylene Glycol, Sodium Benzene Sulfonate, Sodium Lauryl Sulfate, Sodium Tripolyphosphate, Terebinthina, Methanol, Iridium Metallicum, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Phosphoricum Acidum


Deseret Biologicals, Inc.
Human Otc Drug
NDC 43742-1219
Enviroclenz also known as Berberis Vulgaris, Carduus Marianus, Chelidonium Majus, Glycyrrhiza Glabra, Lappa Major, Rhamnus Frangula, Stillingia Sylvatica, Taraxacum Officinale, Trifolium Pratense, Phytolacca Decandra, Germanium Sesquioxide, Benzinum, Chlorinum, Acetone, Ammonium Muriaticum, Propylene Glycol, Sodium Benzene Sulfonate, Sodium Lauryl Sulfate, Sodium Tripolyphosphate, Terebinthina, Methanol, Iridium Metallicum, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Phosphoricum Acidum is a human otc drug labeled by 'Deseret Biologicals, Inc.'. National Drug Code (NDC) number for Enviroclenz is 43742-1219. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Enviroclenz drug includes Acetone - 9 [hp_X]/mL Ammonium Chloride - 9 [hp_X]/mL Arctium Lappa Root - 3 [hp_X]/mL Benzene - 9 [hp_X]/mL Berberis Vulgaris Root Bark - 3 [hp_X]/mL Chelidonium Majus - 3 [hp_X]/mL Chlorine - 10 [hp_X]/mL Frangula Alnus Bark - 3 [hp_X]/mL Germanium Sesquioxide - 8 [hp_X]/mL Glycyrrhiza Glabra - 3 [hp_X]/mL and more. The currest status of Enviroclenz drug is Active.

Drug Information:

Drug NDC: 43742-1219
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Enviroclenz
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Berberis Vulgaris, Carduus Marianus, Chelidonium Majus, Glycyrrhiza Glabra, Lappa Major, Rhamnus Frangula, Stillingia Sylvatica, Taraxacum Officinale, Trifolium Pratense, Phytolacca Decandra, Germanium Sesquioxide, Benzinum, Chlorinum, Acetone, Ammonium Muriaticum, Propylene Glycol, Sodium Benzene Sulfonate, Sodium Lauryl Sulfate, Sodium Tripolyphosphate, Terebinthina, Methanol, Iridium Metallicum, Lycopodium Clavatum, Nitricum Acidum, Nux Vomica, Phosphoricum Acidum
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Deseret Biologicals, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ACETONE - 9 [hp_X]/mL
AMMONIUM CHLORIDE - 9 [hp_X]/mL
ARCTIUM LAPPA ROOT - 3 [hp_X]/mL
BENZENE - 9 [hp_X]/mL
BERBERIS VULGARIS ROOT BARK - 3 [hp_X]/mL
CHELIDONIUM MAJUS - 3 [hp_X]/mL
CHLORINE - 10 [hp_X]/mL
FRANGULA ALNUS BARK - 3 [hp_X]/mL
GERMANIUM SESQUIOXIDE - 8 [hp_X]/mL
GLYCYRRHIZA GLABRA - 3 [hp_X]/mL
IRIDIUM - 12 [hp_X]/mL
LYCOPODIUM CLAVATUM SPORE - 12 [hp_X]/mL
METHYL ALCOHOL - 9 [hp_X]/mL
MILK THISTLE - 3 [hp_X]/mL
NITRIC ACID - 12 [hp_X]/mL
PHOSPHORIC ACID - 12 [hp_X]/mL
PHYTOLACCA AMERICANA ROOT - 4 [hp_X]/mL
PROPYLENE GLYCOL - 9 [hp_X]/mL
SODIUM BENZENESULFONATE - 9 [hp_X]/mL
SODIUM LAURYL SULFATE - 9 [hp_X]/mL
SODIUM TRIPOLYPHOSPHATE - 9 [hp_X]/mL
STILLINGIA SYLVATICA ROOT - 3 [hp_X]/mL
STRYCHNOS NUX-VOMICA SEED - 12 [hp_X]/mL
TARAXACUM OFFICINALE FLOWERING TOP - 3 [hp_X]/mL
TRIFOLIUM PRATENSE LEAF - 3 [hp_X]/mL
TURPENTINE OIL - 9 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 25 Apr, 2018
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 12 Jun, 2023
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 07 May, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Deseret Biologicals, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
NUI:N0000185371
N0000185375
N0000175629
N0000184306
M0000728
M0006342
M0016962
N0000185001
M0516536
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:1364PS73AF
01Q9PC255D
597E9BI3Z3
J64922108F
1TH8Q20J0U
7E889U5RNN
4R7X1O2820
S2D77IH61R
96WE91N25T
2788Z9758H
44448S9773
C88X29Y479
Y4S76JWI15
U946SH95EE
411VRN1TV4
E4GA8884NN
11E6VI8VEG
6DC9Q167V3
K5RM14AZHX
368GB5141J
5HK03SA80J
QBR70R4FBK
269XH13919
DQS85W46HV
612YOZ36DG
C5H0QJ6V7F
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class EPC:Non-Standardized Food Allergenic Extract [EPC]
Non-Standardized Plant Allergenic Extract [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:Increased Histamine Release [PE]
Cell-mediated Immunity [PE]
Increased IgG Production [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:Allergens [CS]
Dietary Proteins [CS]
Plant Proteins [CS]
Seed Storage Proteins [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:Allergens [CS]
Cell-mediated Immunity [PE]
Dietary Proteins [CS]
Increased Histamine Release [PE]
Increased IgG Production [PE]
Non-Standardized Food Allergenic Extract [EPC]
Non-Standardized Plant Allergenic Extract [EPC]
Plant Proteins [CS]
Seed Storage Proteins [CS]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
43742-1219-130 mL in 1 BOTTLE, DROPPER (43742-1219-1)25 Apr, 201812 Jun, 2023No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Homeopathic indications: for temporary relief of symptoms related to toxicity caused by environmental substances including neck pain, hives, occasional constipation, cough, and headache.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

Product Elements:

Enviroclenz berberis vulgaris, carduus marianus, chelidonium majus, glycyrrhiza glabra, lappa major, rhamnus frangula, stillingia sylvatica, taraxacum officinale, trifolium pratense, phytolacca decandra, germanium sesquioxide, benzinum, chlorinum, acetone, ammonium muriaticum, propylene glycol, sodium benzene sulfonate, sodium lauryl sulfate, sodium tripolyphosphate, terebinthina, methanol, iridium metallicum, lycopodium clavatum, nitricum acidum, nux vomica, phosphoricum acidum berberis vulgaris root bark berberis vulgaris root bark milk thistle milk thistle chelidonium majus chelidonium majus glycyrrhiza glabra glycyrrhiza glabra arctium lappa root arctium lappa root frangula alnus bark frangula alnus bark stillingia sylvatica root stillingia sylvatica root taraxacum officinale flowering top taraxacum officinale flowering top trifolium pratense leaf trifolium pratense leaf phytolacca americana root phytolacca americana root germanium sesquioxide germanium sesquioxide benzene benzene acetone acetone ammonium chloride ammonium cation propylene glycol propylene glycol sodium benzenesulfonate benzenesulfonic acid sodium lauryl sulfate lauryl sulfate sodium tripolyphosphate tripolyphosphate ion turpentine oil turpentine oil methyl alcohol methyl alcohol chlorine chlorine iridium iridium lycopodium clavatum spore lycopodium clavatum spore nitric acid nitric acid strychnos nux-vomica seed strychnos nux-vomica seed phosphoric acid phosphoric acid water alcohol

Indications and Usage:

Homeopathic indications: for temporary relief of symptoms related to toxicity caused by environmental substances including neck pain, hives, occasional constipation, cough, and headache.** **these statements are based upon traditional homeopathic principles. they have not been reviewed by the food and drug administration.

Warnings:

Warnings: keep out of reach of children. in case of overdose, contact physician or a poison control center right away. if pregnant or breast-feeding, ask a health professional before use. tamper seal: "sealed for your protection." do not use if seal is broken or missing.

Dosage and Administration:

Directions: 1-10 drops under the tongue, 3 times a day or as directed by a health professional. consult a physician for use in children under 12 years of age.

Package Label Principal Display Panel:

Package label display: des bio ndc 43742-1219-1 homeopathic enviroclenz 1 fl oz (30 ml) enviroclenz

Further Questions:

Questions: dist. by: deseret biologicals, inc. 469 w. parkland drive sandy, ut 84070 www.desbio.com


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.